BioCentury | Jun 1, 2018
Clinical News

Gilead's Epclusa approved in China for HCV

...City, Calif. Product: Epclusa sofosbuvir/velpatasvir Business: Infectious Paul Bonanos Epclusa (Brand), sofosbuvir/GS-5816 (Compound #), sofosbuvir/velpatasvir (Generic), Epclusa (Other) Sovaldi, sofosbuvir (GS-7977, psi-7977) velpatasvir...
BioCentury | Mar 9, 2018
Company News

DNDi, partners aim to bring cheaper HCV combo to Latin America

...Argentina Mundo Sano Foundation, Buenos Aires, Argentina Pharco Corp., Alexandria, Egypt Business: Infectious Jennie Walters ravidasvir (ASC16, PPI-668) Sovaldi, sofosbuvir (GS-7977, psi-7977) Drugs...
BioCentury | Mar 7, 2018
Company News

DNDi, partners aim to bring cheaper HCV combo to Latin America

...certain low- and middle-income countries. Ravidasvir is a second-generation HCV NS5A protein inhibitor. Jennie Walters ravidasvir (ASC16, PPI-668) Sovaldi, sofosbuvir (GS-7977, psi-7977) Drugs...
Items per page:
1 - 3 of 3